Sandler Capital Management Procept Bio Robotics Corp Transaction History
Sandler Capital Management
- $698 Million
- Q3 2024
A detailed history of Sandler Capital Management transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Sandler Capital Management holds 250,000 shares of PRCT stock, worth $24.3 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
250,000Holding current value
$24.3 Million% of portfolio
0.73%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRCT
# of Institutions
267Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$471 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$339 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$149 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$121 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$115 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.34B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...